Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 1
2007 1
2008 1
2009 1
2010 2
2011 1
2014 1
2015 2
2016 1
2017 1
2018 4
2019 3
2020 6
2021 13
2022 7
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Seven classes of antiviral agents.
Ianevski A, Ahmad S, Anunnitipat K, Oksenych V, Zusinaite E, Tenson T, Bjørås M, Kainov DE. Ianevski A, et al. Among authors: zusinaite e. Cell Mol Life Sci. 2022 Nov 27;79(12):605. doi: 10.1007/s00018-022-04635-1. Cell Mol Life Sci. 2022. PMID: 36436108 Free PMC article. Review.
Novel Synergistic Anti-Enteroviral Drug Combinations.
Ianevski A, Zusinaite E, Tenson T, Oksenych V, Wang W, Afset JE, Bjørås M, Kainov DE. Ianevski A, et al. Among authors: zusinaite e. Viruses. 2022 Aug 25;14(9):1866. doi: 10.3390/v14091866. Viruses. 2022. PMID: 36146673 Free PMC article.
Novel activities of safe-in-human broad-spectrum antiviral agents.
Ianevski A, Zusinaite E, Kuivanen S, Strand M, Lysvand H, Teppor M, Kakkola L, Paavilainen H, Laajala M, Kallio-Kokko H, Valkonen M, Kantele A, Telling K, Lutsar I, Letjuka P, Metelitsa N, Oksenych V, Bjørås M, Nordbø SA, Dumpis U, Vitkauskiene A, Öhrmalm C, Bondeson K, Bergqvist A, Aittokallio T, Cox RJ, Evander M, Hukkanen V, Marjomaki V, Julkunen I, Vapalahti O, Tenson T, Merits A, Kainov D. Ianevski A, et al. Among authors: zusinaite e. Antiviral Res. 2018 Jun;154:174-182. doi: 10.1016/j.antiviral.2018.04.016. Epub 2018 Apr 23. Antiviral Res. 2018. PMID: 29698664 Free PMC article. Review.
Antiviral efficacy of cerium oxide nanoparticles.
Nefedova A, Rausalu K, Zusinaite E, Vanetsev A, Rosenberg M, Koppel K, Lilla S, Visnapuu M, Smits K, Kisand V, Tätte T, Ivask A. Nefedova A, et al. Among authors: zusinaite e. Sci Rep. 2022 Nov 5;12(1):18746. doi: 10.1038/s41598-022-23465-6. Sci Rep. 2022. PMID: 36335167 Free PMC article.
Mono- and combinational drug therapies for global viral pandemic preparedness.
Ianevski A, Yao R, Simonsen RM, Myhre V, Ravlo E, Kaynova GD, Zusinaite E, White JM, Polyak SJ, Oksenych V, Windisch MP, Pan Q, Lastauskienė E, Vitkauskienė A, Matukevičius A, Tenson T, Bjørås M, Kainov DE. Ianevski A, et al. Among authors: zusinaite e. iScience. 2022 Mar 17;25(4):104112. doi: 10.1016/j.isci.2022.104112. eCollection 2022 Apr 15. iScience. 2022. PMID: 35402870 Free PMC article. Review.
Potential Antiviral Options against SARS-CoV-2 Infection.
Ianevski A, Yao R, Fenstad MH, Biza S, Zusinaite E, Reisberg T, Lysvand H, Løseth K, Landsem VM, Malmring JF, Oksenych V, Erlandsen SE, Aas PA, Hagen L, Pettersen CH, Tenson T, Afset JE, Nordbø SA, Bjørås M, Kainov DE. Ianevski A, et al. Among authors: zusinaite e. Viruses. 2020 Jun 13;12(6):642. doi: 10.3390/v12060642. Viruses. 2020. PMID: 32545799 Free PMC article.
Boosted production of antibodies that neutralized different SARS-CoV-2 variants in a COVID-19 convalescent following messenger RNA vaccination - a case study.
Ravlo E, Ianevski A, Starheim E, Wang W, Ji P, Lysvand H, Smura T, Kivi G, Voolaid ML, Plaan K, Ustav M, Ustav M Jr, Zusinaite E, Tenson T, Kurg R, Oksenych V, Walstad K, Nordbø SA, Kaarbø M, Ernits K, Bjørås M, Kainov DE, Fenstad MH. Ravlo E, et al. Among authors: zusinaite e. Int J Infect Dis. 2023 Dec;137:75-78. doi: 10.1016/j.ijid.2023.10.011. Epub 2023 Oct 17. Int J Infect Dis. 2023. PMID: 37852599 Free article.
The combination of pleconaril, rupintrivir, and remdesivir efficiently inhibits enterovirus infections in vitro, delaying the development of drug-resistant virus variants.
Ianevski A, Frøysa IT, Lysvand H, Calitz C, Smura T, Schjelderup Nilsen HJ, Høyer E, Afset JE, Sridhar A, Wolthers KC, Zusinaite E, Tenson T, Kurg R, Oksenych V, Galabov AS, Stoyanova A, Bjørås M, Kainov DE. Ianevski A, et al. Among authors: zusinaite e. Antiviral Res. 2024 Apr;224:105842. doi: 10.1016/j.antiviral.2024.105842. Epub 2024 Feb 26. Antiviral Res. 2024. PMID: 38417531 Free article.
50 results